Search Count: 20
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-18 Classification: HYDROLASE Ligands: A1CA4, ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-06-18 Classification: HYDROLASE Ligands: A1CA5, ZN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2022-09-07 Classification: CYTOKINE Ligands: U5I |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2022-09-07 Classification: CYTOKINE Ligands: U5Q |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2022-09-07 Classification: CYTOKINE Ligands: U5X, GOL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2022-09-07 Classification: CYTOKINE Ligands: U6C |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2022-03-02 Classification: SIGNALING PROTEIN, Transferase Ligands: 9ID, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2019-06-26 Classification: CYTOKINE Ligands: O6D |
 |
Crystal Structure Of Protein Kinase A In Complex With The Pki Peptide And An Amino-Pyridinylbenzamide Based Inhibitor.
Organism: Bos taurus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-11-14 Classification: TRANSFERASE Ligands: J0G |
 |
Crystal Structure Of Protein Kinase A In Complex With The Pki Peptide And A Pyridinylbenzamide Based Inhibitor
Organism: Bos taurus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2018-11-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J0P |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.96 Å Release Date: 2018-11-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J0P, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.86 Å Release Date: 2018-11-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: J0P |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: CA, ICT, DWP |
 |
Novel Binding Modes Of Inhibition Of Wild-Type Idh1: Allosteric Inhibition With Cmpd2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: LMR, MG, K32 |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Non-Equivalent Allosteric Inhibition With Cmpd3
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: NAP, DWM |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1:Direct Covalent Modification Of His315 With Cmpd11
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2018-07-25 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE inhibitor Ligands: MG, ICT, DWJ, NAP |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd13
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: ICT, DWG, CA |
 |
Novel Modes Of Inhibition Of Wild-Type Idh1: Direct Covalent Modification Of His315 With Cmpd15
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2018-07-25 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: CA, ICT, DWS |
 |
Crystal Structure Of Human Nampt With Fragment 2: 2-[(2-Fluorophenyl)Amino]-6-Propylpyrimidin-4(3H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2018-01-10 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: AQ1 |
 |
Crystal Structure Of Human Nampt With Fragment 5: (3E)-3-[(Phenylamino)Methylidene]Oxan-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-01-10 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: AOY, SO4 |